Berry Street Capital Management LLP Gelesis Holdings, Inc. Call Options Transaction History

Berry Street Capital Management LLP

  • $340 Million
  • Q3 2023

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022
SELL
N/A
-50,000 Closed
0 $0
Q1 2022

May 13, 2022
BUY
N/A
50,000 New
50,000 $227,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Berry Street Capital Management LLP Portfolio

Follow Berry Street Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Berry Street Capital Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email